Ludwig Boltzmann Institute
Hematology and Oncology

Welcome
to the Ludwig Boltzmann Institute for Hematology and Oncology (LBI HO)
The overarching goal of the Ludwig Boltzmann Institute for Hematology and Oncology (formerly Ludwig Boltzmann Cluster Oncology (LBC ONC)) is to develop new therapeutic concepts in cancer research aiming at eliminating cancer stem cells in leukemias and solid tumors.
The individual tasks are derived from the successful collaboration of preclinical basic research and clinical medicine in the field of tumor stem cell research.
Molecular cell and tissue research results are being implemented in the development of new strategies for cancer and leukemia treatment.
The research objectives are determined by new concepts for clinical applications that are the outcome of results from our in vitro– studies.
News
-
The LBI HO invites:
LBI für Hämatologie und Onkologie
16 Mar 2023 -
Congratulations to Dr. Barbara Peter on a new publication
We congratulate Dr. Barbara Peter on the publication of her work on the topic of targeted inhibit…
LBI für Hämatologie und Onkologie
13 Feb 2023 -
Evaluation 2021
On November 10th and 11th, 2021, the performance of the Ludwig Boltzmann Institute for Hematology…
LBI für Hämatologie und Onkologie
17 Jun 2022
-
Scientific Advisory Board Meeting 2019
On Friday, November 8th, 2019 the annual Scientific Advisory Board (SAB) of the LBI HO took place…
LBI für Hämatologie und Onkologie
02 Dec 2019 -
Thomas Grunt received Asclepius-Award
Thomas Grunt, Deputy Scientific Coordinator of the LBI HO, is Principal Investigator of an award-…
LBI für Hämatologie und Onkologie
14 Nov 2019
-
The LBI HO invites:
LBI für Hämatologie und Onkologie
16 Mar 2023 -
Congratulations to Dr. Barbara Peter on a new publication
We congratulate Dr. Barbara Peter on the publication of her work on the topic of targeted inhibit…
LBI für Hämatologie und Onkologie
13 Feb 2023 -
Evaluation 2021
On November 10th and 11th, 2021, the performance of the Ludwig Boltzmann Institute for Hematology…
LBI für Hämatologie und Onkologie
17 Jun 2022 -
Scientific Advisory Board Meeting 2019
On Friday, November 8th, 2019 the annual Scientific Advisory Board (SAB) of the LBI HO took place…
LBI für Hämatologie und Onkologie
02 Dec 2019 -
Thomas Grunt received Asclepius-Award
Thomas Grunt, Deputy Scientific Coordinator of the LBI HO, is Principal Investigator of an award-…
LBI für Hämatologie und Onkologie
14 Nov 2019